drugset / Trial / NCT05708391
Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in Children
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical trial\]is to evaluate the efficacy, safety and feasibility of radiotherapy combined with Realgar-Indigo naturalis formula（An oral arsenic agent）in the treatment of rhabdomyosarcoma in children. Including the occurrence of adverse events and the improvement of quality of life.
Timeline
- Start
- 2023-01-31
- Primary completion
- 2024-03-31
- Completion
- 2024-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Realgar-Indigo Naturalis Formula | Traditional medicine (herbal / TCM) | 60 mg/kg | Oral |